Searchable abstracts of presentations at key conferences in endocrinology

ea0038p449 | Thyroid | SFEBES2015

Serum thyroid stimulating hormone concentration after withdrawal of thionamides as a predictor of Graves’ disease outcome

Nalla Preethi , Adlan Mohamed , Premawardhana Lakdasa D

Introduction: Despite high rates of recurrence after anti-thyroid drug (ATD) withdrawal, ATD (mainly Carbmazole) remain the first line of treatment for Graves’ disease (GD) in the UK. Limited retrospective observational studies have shown that a low TSH post ATD withdrawal had a positive predictive value of 70% and a negative predictive value of 62% (specificity 85%) for relapse of Graves’ disease.Aim: We wished to determine the relationship be...

ea0037ep1321 | Clinical Cases–Thyroid/Other | ECE2015

Can pericardial effusion be a manifestation of Graves' disease? An unusual case

Besis George , Kyriakakis Nikolaos , Premawardhana Lakdasa D

Introduction: Graves’ disease (GD) is associated with a number of cardiovascular complications, including rhythm disturbances, mitral valve prolapse, pulmonary hypertension and heart failure. Pericardial effusion in the context of GD has only been reported in a small number of cases.Case: A 59-year-old gentleman presented with a 3-day history of dyspnoea and pleuritic chest pain. He had a previous history of GD 8 months ago, pulmonary embolism (PE),...